Ally Bridge Group (Ny) LLC Gossamer Bio, Inc. Transaction History

Ally Bridge Group (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $2.33 Million - $4.81 Million	-323,000 Reduced 46.14%	377,000 $4.52 Million
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $1.49 Million - $2.49 Million	250,000 Added 55.56%	700,000 $5.86 Million
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $211,000 - $312,250	-25,000 Reduced 5.26%	450,000 $3.91 Million
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $7.08 Million - $9.85 Million	-700,000 Reduced 59.57%	475,000 $5.37 Million
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $9.4 Million - $11.5 Million	1,175,000 New	1,175,000 $9.54 Million

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.